“Viral” myocarditis in a patient following allogenic stem cell transplant: Diagnostic dilemma and management considerations

Bhattacharya, Sanjay; Paneesha, Shankara; Chaganti, Sridhar; Lovell, Richard; Slocombe, G. W.; Milligan, Donald; Osman, Husam

doi:10.1016/j.jcv.2009.05.005

Search citation statements

Order By: Relevance

Paper Sections

Select...

Introduction1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2017

2020

Publication Types

Select...

Article1

Book1

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

(1 citation statement)

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, allo-SCT recipients have multiple factors that may lead to myocarditis, including a high risk of viral infection and allogeneic immune reactions. Therefore, the management of myocarditis in allo-SCT recipients is thought to be more complicated and difficult than in nontransplant patients (8).…”

Section: Introductionmentioning

confidence: 99%

Myocarditis with Advanced Atrioventricular Block after Allogeneic Stem Cell Transplantation: A Case Report and Literature Review

et al. 2020

View full text Add to dashboard Cite

A 51-year-old woman with Philadelphia chromosome-positive acute lymphoblastic leukemia underwent a second cord blood transplantation followed by maintenance therapy with interferon-α. After 33 months, she developed cardiogenic shock caused by advanced atrioventricular block. Laboratory tests revealed increased myocardium enzymes, and ultrasonic cardiography demonstrated mild thickening of the left ventricular wall. She was diagnosed with myocarditis and successfully treated using prednisolone. Myocarditis after allogeneic stem cell transplantation is a rare but potentially fatal complication. However, it is important for physicians to be aware of this complication because all of the symptoms may be reversed with immunosuppressive treatment.

show abstract

Section: Introductionmentioning

confidence: 99%